Sharon E. Underberg - Aug 8, 2025 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Signature
/s/ Lily J. Lu, Attorney-in-Fact for Sharon E. Underberg
Stock symbol
IDXX
Transactions as of
Aug 8, 2025
Transactions value $
-$2,323,830
Form type
4
Date filed
8/12/2025, 05:00 PM
Previous filing
Feb 18, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Underberg Sharon E. EVP, GC & Corporate Secretary ONE IDEXX DRIVE, WESTBROOK /s/ Lily J. Lu, Attorney-in-Fact for Sharon E. Underberg 2025-08-12 0001630353

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $1.13M +5.45K +88.54% $206.94 11.6K Aug 8, 2025 Direct F1
transaction IDXX Common Stock Sale -$3.55M -5.45K -46.96% $651.60 6.16K Aug 8, 2025 Direct
transaction IDXX Common Stock Options Exercise $99.6K +183 +2.97% $544.08 6.34K Aug 12, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise $0 -5.45K -100% $0.00 0 Aug 8, 2025 Common Stock 5.45K $206.94 Direct F2
transaction IDXX Incentive Stock Option (right-to-buy) Options Exercise $0 -183 -100% $0.00 0 Aug 12, 2025 Common Stock 183 $544.08 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 28.7090 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2025 and June 30, 2025.
F2 Grant of option to buy shares of Issuer common stock that became exercisable in four annual installments beginning on February 14, 2020.
F3 Grant of option to buy shares of Issuer common stock that became exercisable in one installment on February 14, 2025.